Treatment of malignant pleural effusions: the case for localized immunotherapy

Longitudinal Measurement of Pleural Fluid Biochemistry and Cytokines in Malignant Pleural Effusions

(2016) Rajesh Thomas et al.   CHEST

Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages

(2016) Lifeng Li et al.   INTERNATIONAL JOURNAL OF CANCER

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages

(2014) Haihui Lu et al.   NATURE CELL BIOLOGY

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

(2014) Shannon L. Maude et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score

(2014) Amelia O Clive et al.   THORAX

PD-L1 Expression in Triple-Negative Breast Cancer

(2014) E. A. Mittendorf et al.   Cancer Immunology Research

Possible Role for Tocilizumab, an Anti–Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia

(2012) Katsutoshi Ando et al.   JOURNAL OF CLINICAL ONCOLOGY

VEGF and sVEGFR-1 in malignant pleural effusions: Association with survival and pleurodesis outcomes

(2012) C.E. Hooper et al.   LUNG CANCER

Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks

(2012) Deepali Malhotra et al.   NATURE IMMUNOLOGY

The pro- and anti-inflammatory properties of the cytokine interleukin-6

(2011) Jürgen Scheller et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients

(2010) Peter Ruf et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer

(2010) Chi-Wen Lo et al.   CANCER RESEARCH

Management of Malignant Pleural Effusions Using the Pleurx Catheter

(2008) William H. Warren et al.   ANNALS OF THORACIC SURGERY